166 related articles for article (PubMed ID: 38331471)
21. Incidence of giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.
Brekke LK; Diamantopoulos AP; Fevang BT; Aβmus J; Esperø E; Gjesdal CG
Arthritis Res Ther; 2017 Dec; 19(1):278. PubMed ID: 29246164
[TBL] [Abstract][Full Text] [Related]
22. [SHOULD PATIENTS WITH GIANT CELL ARTERITIS BE TESTED FOR AORTIC ANEURYSMS?].
Milchert M; Brzosko M
Ann Acad Med Stetin; 2014; 60(2):37-9. PubMed ID: 26591105
[TBL] [Abstract][Full Text] [Related]
23. Mortality among Patients with Giant Cell Arteritis: A Large-scale Population-based Cohort Study.
Ben-Shabat N; Tiosano S; Shovman O; Comaneshter D; Shoenfeld Y; Cohen AD; Amital H
J Rheumatol; 2020 Sep; 47(9):1385-1391. PubMed ID: 31839591
[TBL] [Abstract][Full Text] [Related]
24. Mega-aorta syndrome development in giant cell arteritis. A same entity?
Rodríguez-Caulo EA; Velázquez CJ; García-Borbolla M; Barquero JM
Ann Vasc Surg; 2011 Nov; 25(8):1141.e1-3. PubMed ID: 22023949
[TBL] [Abstract][Full Text] [Related]
25. Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases.
Boiardi L; Galli E; Macchioni P; Muratore F; Klinowski G; Hunder GG; Casali M; Besutti G; Spaggiari L; Versari A; Croci S; Mancuso P; Rossi PG; Marvisi C; Salvarani C
Semin Arthritis Rheum; 2023 Apr; 59():152173. PubMed ID: 36780709
[TBL] [Abstract][Full Text] [Related]
26. Lower Frequency of Comorbidities Prior to Onset of Giant Cell Arteritis: A Population-Based Study.
Elfishawi M; Rakholiya J; Gunderson TM; Achenbach SJ; Crowson CS; Matteson EL; Turesson C; Wadström K; Weyand C; Koster MJ; Warrington KJ
J Rheumatol; 2023 Apr; 50(4):526-531. PubMed ID: 36521923
[TBL] [Abstract][Full Text] [Related]
27. Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study.
Lo Gullo A; Koster MJ; Crowson CS; Makol A; Ytterberg SR; Saitta A; Salvarani C; Matteson EL; Warrington KJ
PLoS One; 2016; 11(2):e0149579. PubMed ID: 26901431
[TBL] [Abstract][Full Text] [Related]
28. A nationwide study of ocular manifestations leading to hospital contacts among patients with giant cell arteritis.
Therkildsen P; de Thurah A; Faurschou M; Baslund B; Hansen IT; Nørgaard M; Nielsen BD; Hauge EM
Semin Arthritis Rheum; 2022 Oct; 56():152071. PubMed ID: 35878473
[TBL] [Abstract][Full Text] [Related]
29. [Giant cell arteritis].
Calvo Romero JM
An Med Interna; 2002 May; 19(5):257-62. PubMed ID: 12108003
[TBL] [Abstract][Full Text] [Related]
30. Evaluating the Incidence of Arteritic Ischemic Optic Neuropathy and Other Causes of Vision Loss from Giant Cell Arteritis.
Chen JJ; Leavitt JA; Fang C; Crowson CS; Matteson EL; Warrington KJ
Ophthalmology; 2016 Sep; 123(9):1999-2003. PubMed ID: 27297405
[TBL] [Abstract][Full Text] [Related]
31. The incidence of giant cell arteritis in Slovenia.
Pucelj NP; Hočevar A; Ješe R; Rotar Ž; Hawlina M; Fakin A; Pižem J; Tomšič M
Clin Rheumatol; 2019 Feb; 38(2):285-290. PubMed ID: 30062445
[TBL] [Abstract][Full Text] [Related]
32. The incidence of giant cell arteritis in Olmsted County, Minnesota, over a 60-year period 1950-2009.
Chandran AK; Udayakumar PD; Crowson CS; Warrington KJ; Matteson EL
Scand J Rheumatol; 2015 May; 44(3):215-8. PubMed ID: 25606666
[TBL] [Abstract][Full Text] [Related]
33. Survival and death causes of patients with giant cell arteritis in Western Norway 1972-2012: a retrospective cohort study.
Brekke LK; Fevang BS; Diamantopoulos AP; Assmus J; Esperø E; Gjesdal CG
Arthritis Res Ther; 2019 Jun; 21(1):154. PubMed ID: 31238961
[TBL] [Abstract][Full Text] [Related]
34. Prognosis and monitoring of giant cell arteritis and associated complications.
Kermani TA; Warrington KJ
Expert Rev Clin Immunol; 2018 May; 14(5):379-388. PubMed ID: 29676201
[TBL] [Abstract][Full Text] [Related]
35. Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden.
Stamatis P; Mohammad MA; Gisslander K; Merkel PA; Englund M; Turesson C; Erlinge D; Mohammad AJ
RMD Open; 2024 Apr; 10(2):. PubMed ID: 38599652
[TBL] [Abstract][Full Text] [Related]
36. Malignancy risk in patients with giant cell arteritis: a population-based cohort study.
Kermani TA; Schäfer VS; Crowson CS; Hunder GG; Gabriel SE; Ytterberg SR; Matteson EL; Warrington KJ
Arthritis Care Res (Hoboken); 2010 Feb; 62(2):149-54. PubMed ID: 20191512
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period.
González-Gay MA; Garcia-Porrua C; Rivas MJ; Rodriguez-Ledo P; Llorca J
Ann Rheum Dis; 2001 Apr; 60(4):367-71. PubMed ID: 11247867
[TBL] [Abstract][Full Text] [Related]
38. Persistent aortic inflammation in patients with giant cell arteritis.
Kaymakci MS; Boire NA; Bois MC; Elfishawi MM; Langenfeld HE; Hanson AC; Crowson CS; Koster MJ; Sato Y; Weyand CM; Warrington KJ
Autoimmun Rev; 2023 Sep; 22(9):103411. PubMed ID: 37597603
[TBL] [Abstract][Full Text] [Related]
39. Risk factors for symptomatic vascular events in giant cell arteritis: a study of 254 patients with large-vessel imaging at diagnosis.
de Mornac D; Agard C; Hardouin JB; Hamidou M; Connault J; Masseau A; Espitia-Thibault A; Artifoni M; Ngohou C; Perrin F; Graveleau J; Durant C; Pottier P; Néel A; Espitia O
Ther Adv Musculoskelet Dis; 2021; 13():1759720X211006967. PubMed ID: 34249150
[TBL] [Abstract][Full Text] [Related]
40. Giant cell arteritis-related aortic dissection: A multicenter retrospective study.
de Boysson H; Espitia O; Samson M; Tieulié N; Bachmeyer C; Moulinet T; Dumont A; Deshayes S; Bonnotte B; Agard C; Aouba A;
Semin Arthritis Rheum; 2021 Apr; 51(2):430-435. PubMed ID: 33690049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
